{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T07:16:13Z","timestamp":1778570173538,"version":"3.51.4"},"reference-count":61,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Science Center","award":["2019\/35\/O\/NZ1\/03535"],"award-info":[{"award-number":["2019\/35\/O\/NZ1\/03535"]}]},{"DOI":"10.13039\/501100011755","name":"National Center for Research and Development","doi-asserted-by":"publisher","award":["LIDER15\/0156\/2024"],"award-info":[{"award-number":["LIDER15\/0156\/2024"]}],"id":[{"id":"10.13039\/501100011755","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Dystrogen Gene Therapies Inc."},{"DOI":"10.13039\/501100020811","name":"IBCH PAS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020811","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Huntington\u2019s disease (HD) is the best-known example of a neurodegenerative disorder caused by the expansion of a glutamine-encoding CAG repeat in the causative gene. Growing evidence indicates that somatic CAG expansions play a key role in disease progression, providing a strong rationale for therapeutic strategies directly targeting the repeat tract. However, achieving sufficient efficacy while maintaining allele selectivity and minimizing off-target effects remains a major challenge. Here, we developed allele-selective, CAG-targeting artificial microRNA (amiRNA) molecules that exhibit significantly reduced off-target risk. This was achieved by introducing specific substitutions at selected positions within the guide strand. These molecules effectively downregulated polyglutamine (polyQ) proteins in cellular models of HD, spinocerebellar ataxias types 1 and 3, and dentatorubral pallidoluysian atrophy. The most promising candidate, amiR136-13A, reduced mutant huntingtin levels in different brain regions of the HD mouse model and did not induce toxicity up to 28 weeks following a single administration of an AAV5 vector. Transcriptomic profiling of human HD neural stem cells treated with amiR136-13A revealed minor changes in gene expression. Moreover, amiR136-13A reduced the level of HTT1a, a short pathogenic isoform of huntingtin. Collectively, these findings identify amiR136-13A as a potent, selective, and safe therapeutic candidate for HD and potentially other polyQ disorders.<\/jats:p>","DOI":"10.1093\/narmme\/ugag023","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:35:29Z","timestamp":1777563329000},"source":"Crossref","is-referenced-by-count":0,"title":["CAG-targeting artificial miRNA with reduced off-target risk for efficient lowering of pathogenic polyglutamine proteins"],"prefix":"10.1093","volume":"3","author":[{"given":"Marianna","family":"Pewinska-Kolodziejczak","sequence":"first","affiliation":[{"name":"Department of Genome Engineering, Institute of Bioorganic Chemistry, Polish Academy of Sciences , Noskowskiego 12\/14, 61-704 Poznan ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Kotowska-Zimmer","sequence":"additional","affiliation":[{"name":"Department of Genome Engineering, Institute of Bioorganic Chemistry, Polish Academy of Sciences , Noskowskiego 12\/14, 61-704 Poznan ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukasz","family":"Przybyl","sequence":"additional","affiliation":[{"name":"Laboratory of Mammalian Model Organisms, Institute of Bioorganic Chemistry, Polish Academy of Sciences , Noskowskiego 12\/14, 61-704 Poznan ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"Wronka","sequence":"additional","affiliation":[{"name":"Laboratory of Mammalian Model Organisms, Institute of Bioorganic Chemistry, Polish Academy of Sciences , Noskowskiego 12\/14, 61-704 Poznan ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Karlik","sequence":"additional","affiliation":[{"name":"Laboratory of Mammalian Model Organisms, Institute of Bioorganic Chemistry, Polish Academy of Sciences , Noskowskiego 12\/14, 61-704 Poznan ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Smuszkiewicz","sequence":"additional","affiliation":[{"name":"Department of Genome Engineering, Institute of Bioorganic Chemistry, Polish Academy of Sciences , Noskowskiego 12\/14, 61-704 Poznan ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Balcerek","sequence":"additional","affiliation":[{"name":"Department of Genome Engineering, Institute of Bioorganic Chemistry, Polish Academy of Sciences , Noskowskiego 12\/14, 61-704 Poznan ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Suszynska-Zajczyk","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Biotechnology, Poznan University of Life Sciences , 60-632 Poznan ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Piaszyk-Borychowska","sequence":"additional","affiliation":[{"name":"Department of Genome Engineering, Institute of Bioorganic Chemistry, Polish Academy of Sciences , Noskowskiego 12\/14, 61-704 Poznan ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martyna","family":"Urbanek-Trzeciak","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics, Institute of Bioorganic Chemistry, Polish Academy of Sciences , Noskowskiego 12\/14, 61-704 Poznan ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Sablok","sequence":"additional","affiliation":[{"name":"Laboratory of Genomics, Institute of Bioorganic Chemistry, Polish Academy of Sciences , Noskowskiego 12\/14, 61-704 Poznan ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Kozlowska","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology, Institute of Bioorganic Chemistry, Polish Academy of Sciences , Noskowskiego 12\/14, 61-704 Poznan ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Podkowinski","sequence":"additional","affiliation":[{"name":"Laboratory of Genomics, Institute of Bioorganic Chemistry, Polish Academy of Sciences , Noskowskiego 12\/14, 61-704 Poznan ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Fiszer","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology, Institute of Bioorganic Chemistry, Polish Academy of Sciences , Noskowskiego 12\/14, 61-704 Poznan ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3770-7715","authenticated-orcid":false,"given":"Piotr","family":"Kozlowski","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics, Institute of Bioorganic Chemistry, Polish Academy of Sciences , Noskowskiego 12\/14, 61-704 Poznan ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiza","family":"Handschuh","sequence":"additional","affiliation":[{"name":"Laboratory of Genomics, Institute of Bioorganic Chemistry, Polish Academy of Sciences , Noskowskiego 12\/14, 61-704 Poznan ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8471-6302","authenticated-orcid":false,"given":"Marta","family":"Olejniczak","sequence":"additional","affiliation":[{"name":"Department of Genome Engineering, Institute of Bioorganic Chemistry, Polish Academy of Sciences , Noskowskiego 12\/14, 61-704 Poznan ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"2026051202565897400_B1","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/ana.410360604","article-title":"Trinucleotide repeat expansion in neurological disease","volume":"36","author":"La\u00a0Spada","year":"1994","journal-title":"Ann Neurol"},{"key":"2026051202565897400_B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-pathmechdis-012418-012857","article-title":"Polyglutamine repeats in neurodegenerative diseases","volume":"14","author":"Lieberman","year":"2019","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"2026051202565897400_B3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13578-025-01443-5","article-title":"HTT loss-of-function contributes to RNA deregulation in developing Huntington\u2019s disease neurons","volume":"15","author":"Koz\u0142owska","year":"2025","journal-title":"Cell Biosci"},{"key":"2026051202565897400_B4","doi-asserted-by":"publisher","first-page":"104637","DOI":"10.1016\/j.nbd.2019.104637","article-title":"Loss of huntingtin function slows synaptic vesicle endocytosis in striatal neurons from the httQ140\/Q140 mouse model of Huntington\u2019s disease","volume":"134","author":"McAdam","year":"2020","journal-title":"Neurobiol Dis"},{"key":"2026051202565897400_B5","doi-asserted-by":"publisher","first-page":"hzv005","DOI":"10.1093\/biohorizons\/hzv005","article-title":"Does loss of the normal protein function contribute to the pathogenesis of Huntington\u2019s disease?","volume":"8","author":"Paine","year":"2015","journal-title":"Biosci Horiz"},{"key":"2026051202565897400_B6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/378403a0","article-title":"Polyglutamine expansion as a pathological epitope in Huntington\u2019s disease and four dominant cerebellar ataxias","volume":"378","author":"Trottier","year":"1995","journal-title":"Nature"},{"key":"2026051202565897400_B7","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","author":"Macdonald","year":"1993","journal-title":"Cell"},{"key":"2026051202565897400_B8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington\u2019s disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol"},{"key":"2026051202565897400_B9","doi-asserted-by":"publisher","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"2026051202565897400_B10","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.cell.2024.11.038","article-title":"Long somatic DNA-repeat expansion drives neurodegeneration in Huntington\u2019s disease","volume":"188","author":"Handsaker","year":"2025","journal-title":"Cell"},{"key":"2026051202565897400_B11","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1093\/hmg\/ddaa139","article-title":"Patterns of CAG repeat instability in the central nervous system and periphery in Huntington\u2019s disease and in spinocerebellar ataxia type 1","volume":"29","author":"Mouro\u00a0Pinto","year":"2020","journal-title":"Hum Mol Genet"},{"key":"2026051202565897400_B12","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1093\/hmg\/ddp242","article-title":"Somatic expansion of the Huntington\u2019s disease CAG repeat in the brain is associated with an earlier age of disease onset","volume":"18","author":"Swami","year":"2009","journal-title":"Hum Mol Genet"},{"key":"2026051202565897400_B13","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/ng0893-387","article-title":"Trinucleotide repeat length instability and age of onset in Huntington\u2019s disease","volume":"4","author":"Duyao","year":"1993","journal-title":"Nat Genet"},{"key":"2026051202565897400_B14","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1073\/pnas.1221891110","article-title":"Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease","volume":"110","author":"Sathasivam","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026051202565897400_B15","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1038\/s41467-018-06281-3","article-title":"Regulatory mechanisms of incomplete huntingtin mRNA splicing","volume":"9","author":"Neueder","year":"2018","journal-title":"Nat Commun"},{"key":"2026051202565897400_B16","doi-asserted-by":"publisher","first-page":"4409","DOI":"10.1093\/brain\/awac241","article-title":"Alternative processing of human HTT mRNA with implications for Huntington\u2019s disease therapeutics","volume":"145","author":"Fienko","year":"2022","journal-title":"Brain"},{"key":"2026051202565897400_B17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s10020-024-00801-2","article-title":"Huntingtin HTT1a is generated in a CAG repeat-length-dependent manner in human tissues","volume":"30","author":"Hoschek","year":"2024","journal-title":"Mol Med"},{"key":"2026051202565897400_B18","doi-asserted-by":"publisher","first-page":"8139","DOI":"10.1096\/fj.201902277RR","article-title":"Expression of mutant exon 1 huntingtin fragments in human neural stem cells and neurons causes inclusion formation and mitochondrial dysfunction","volume":"34","author":"Ghosh","year":"2020","journal-title":"FASEB J"},{"key":"2026051202565897400_B19","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1038\/s41467-018-06281-3","article-title":"Regulatory mechanisms of incomplete huntingtin mRNA splicing","volume":"9","author":"Neueder","year":"2018","journal-title":"Nat Commun"},{"key":"2026051202565897400_B20","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.3390\/ijms21062146","article-title":"Huntingtin lowering strategies","volume":"21","author":"Marxreiter","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2026051202565897400_B21","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s44321-023-00020-y","article-title":"Lowering mutant huntingtin by small molecules relieves Huntington\u2019s disease symptoms and progression","volume":"16","author":"Bahat","year":"2024","journal-title":"EMBO Mol Med"},{"key":"2026051202565897400_B22","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.neuron.2019.01.039","article-title":"Huntingtin lowering strategies for disease modification in Huntington\u2019s disease","volume":"101","author":"Tabrizi","year":"2019","journal-title":"Neuron"},{"key":"2026051202565897400_B23","doi-asserted-by":"publisher","first-page":"e1006846","DOI":"10.1371\/journal.pgen.1006846","article-title":"Elimination of huntingtin in the adult mouse leads to progressive behavioral deficits, bilateral thalamic calcification, and altered brain iron homeostasis","volume":"13","author":"Dietrich","year":"2017","journal-title":"PLoS Genet"},{"key":"2026051202565897400_B24","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1073\/pnas.1524575113","article-title":"Ablation of huntingtin in adult neurons is nondeleterious but its depletion in young mice causes acute pancreatitis","volume":"113","author":"Wang","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026051202565897400_B25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1471-213X-5-17","article-title":"Inactivation of the Huntington\u2019s disease gene (Hdh) impairs anterior streak formation and early patterning of the mouse embryo","volume":"5","author":"Woda","year":"2005","journal-title":"BMC Dev Biol"},{"key":"2026051202565897400_B26","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.omtn.2022.04.031","article-title":"A CAG repeat-targeting artificial miRNA lowers the mutant huntingtin level in the YAC128 model of Huntington\u2019s disease","volume":"28","author":"Kotowska-Zimmer","year":"2022","journal-title":"Mol Ther Nucleic Acids"},{"key":"2026051202565897400_B27","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.chembiol.2010.10.013","article-title":"Allele-selective inhibition of huntingtin expression by switching to an miRNA-like RNAi mechanism","volume":"17","author":"Hu","year":"2010","journal-title":"Chem Biol"},{"key":"2026051202565897400_B28","doi-asserted-by":"publisher","first-page":"10426","DOI":"10.1093\/nar\/gkt825","article-title":"Self-duplexing CUG repeats selectively inhibit mutant huntingtin expression","volume":"41","author":"Fiszer","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"2026051202565897400_B29","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.omtn.2019.12.012","article-title":"Universal RNAi triggers for the specific inhibition of mutant huntingtin, atrophin-1, ataxin-3, and ataxin-7 expression","volume":"19","author":"Kotowska-Zimmer","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"2026051202565897400_B30","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00018-020-03596-7","article-title":"Artificial miRNAs targeting CAG repeat expansion in ORFs cause rapid deadenylation and translation inhibition of mutant transcripts","volume":"78","author":"Ciesiolka","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"2026051202565897400_B31","doi-asserted-by":"publisher","first-page":"11270","DOI":"10.1093\/nar\/gks907","article-title":"Mechanism of allele-selective inhibition of huntingtin expression by duplex RNAs that target CAG repeats: function through the RNAi pathway","volume":"40","author":"Hu","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"2026051202565897400_B32","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/nar\/gkab1256","article-title":"Reexamining assumptions about miRNA-guided gene silencing","volume":"50","author":"Kilikevicius","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"2026051202565897400_B33","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/gt.2017.71","article-title":"AAV5-miHTT gene therapy demonstrates suppression of mutant huntingtin aggregation and neuronal dysfunction in a rat model of Huntington\u2019s disease","volume":"24","author":"Miniarikova","year":"2017","journal-title":"Gene Ther"},{"key":"2026051202565897400_B34","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41434-020-0178-0","article-title":"Transduction patterns in the CNS following various routes of AAV-5-mediated gene delivery","volume":"28","author":"Pietersz","year":"2021","journal-title":"Gene Ther"},{"key":"2026051202565897400_B35","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/mt.2013.285","article-title":"Recombinant AAV as a platform for translating the therapeutic potential of RNA interference","volume":"22","author":"Borel","year":"2014","journal-title":"Mol Ther"},{"key":"2026051202565897400_B36","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1128\/CMR.00008-08","article-title":"Gene therapy using adeno-associated virus vectors","volume":"21","author":"Daya","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"2026051202565897400_B37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"2026051202565897400_B38","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The Sequence Alignment\/Map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"2026051202565897400_B39","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"2026051202565897400_B40","article-title":"PCAtools: principal component analysis for bioconductor. version 2.20.0","author":"Blighe","year":"2025"},{"key":"2026051202565897400_B41","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1093\/hmg\/dds037","article-title":"Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice","volume":"21","author":"Pouladi","year":"2012","journal-title":"Hum Mol Genet"},{"key":"2026051202565897400_B42","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum Mol Genet"},{"key":"2026051202565897400_B43","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1093\/hmg\/ddl072","article-title":"Body weight is modulated by levels of full-length Huntingtin","volume":"15","author":"Van\u00a0Raamsdonk","year":"2006","journal-title":"Hum Mol Genet"},{"key":"2026051202565897400_B44","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S1474-4422(17)30124-2","article-title":"Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington\u2019s disease: a retrospective cohort analysis","volume":"16","author":"Byrne","year":"2017","journal-title":"Lancet Neurol"},{"key":"2026051202565897400_B45","doi-asserted-by":"publisher","first-page":"eaat7108","DOI":"10.1126\/scitranslmed.aat7108","article-title":"Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington\u2019s disease","volume":"10","author":"Byrne","year":"2018","journal-title":"Sci Transl Med"},{"key":"2026051202565897400_B46","doi-asserted-by":"publisher","first-page":"fcae410","DOI":"10.1093\/braincomms\/fcae410","article-title":"Mutant huntingtin protein decreases with CAG repeat expansion: implications for therapeutics and bioassays","volume":"6","author":"Landles","year":"2024","journal-title":"Brain Commun"},{"key":"2026051202565897400_B47","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1093\/brain\/awae266","article-title":"Exon 1-targeting miRNA reduces the pathogenic exon 1 HTT protein in Huntington\u2019s disease models","volume":"147","author":"Sogorb-Gonzalez","year":"2024","journal-title":"Brain"},{"key":"2026051202565897400_B48","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","article-title":"Metazoan microRNAs","volume":"173","author":"Bartel","year":"2018","journal-title":"Cell"},{"key":"2026051202565897400_B49","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1093\/bioinformatics\/btu045","article-title":"Composition of seed sequence is a major determinant of microRNA targeting patterns","volume":"30","author":"Wang","year":"2014","journal-title":"Bioinformatics"},{"key":"2026051202565897400_B50","doi-asserted-by":"publisher","first-page":"gkaf364","DOI":"10.1093\/nar\/gkaf364","article-title":"Mapping effective microRNA pairing beyond the seed using abasic modifications","volume":"53","author":"Kosek","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"2026051202565897400_B51","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"2026051202565897400_B52","doi-asserted-by":"publisher","first-page":"102206","DOI":"10.1016\/j.omtn.2024.102206","article-title":"Sequencing-guided design of genetically encoded small RNAs targeting CAG repeats for selective inhibition of mutant huntingtin","volume":"35","author":"Parasrampuria","year":"2024","journal-title":"Mol Ther Nucleic Acids"},{"key":"2026051202565897400_B53","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nbt.3807","article-title":"Prediction of potent shRNAs with a sequential classification algorithm","volume":"35","author":"Pelossof","year":"2017","journal-title":"Nat Biotechnol"},{"key":"2026051202565897400_B54","doi-asserted-by":"publisher","first-page":"102738","DOI":"10.1101\/2024.01.09.574789","article-title":"shRNAI: a deep neural network for the design of highly potent shRNAs","volume":"36","author":"Park","year":"2025","journal-title":"Mol Ther Nucleic Acids"},{"key":"2026051202565897400_B55","doi-asserted-by":"crossref","first-page":"e1640","DOI":"10.1002\/wrna.1640","article-title":"Artificial miRNAs as therapeutic tools: challenges and opportunities","volume":"12","author":"Kotowska-Zimmer","journal-title":"WIREs RNA"},{"key":"2026051202565897400_B56","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.bbagrm.2016.02.014","article-title":"siRNA release from pri-miRNA scaffolds is controlled by the sequence and structure of RNA","volume":"1859","author":"Galka-Marciniak","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"2026051202565897400_B57","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40035-024-00443-8","article-title":"Elevated plasma and CSF neurofilament light chain concentrations are stabilized in response to mutant huntingtin lowering in the brains of Huntington\u2019s disease mice","volume":"13","author":"Caron","year":"2024","journal-title":"Transl Neurodegener"},{"key":"2026051202565897400_B58","doi-asserted-by":"publisher","first-page":"fcae030","DOI":"10.1093\/braincomms\/fcae030","article-title":"Translatable plasma and CSF biomarkers for use in mouse models of Huntington\u2019s disease","volume":"6","author":"Bondulich","year":"2024","journal-title":"Brain Commun"},{"key":"2026051202565897400_B59","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/gt.2017.14","article-title":"MR-guided parenchymal delivery of adeno-associated viral vector serotype 5 in non-human primate brain","volume":"24","author":"Samaranch","year":"2017","journal-title":"Gene Ther"},{"key":"2026051202565897400_B60","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1177\/18796397241293955","article-title":"Huntington\u2019s disease clinical trials update: September 2024","volume":"13","author":"Farag","year":"2024","journal-title":"J Huntington Dis"},{"key":"2026051202565897400_B61","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.nbd.2009.05.007","article-title":"Systematic behavioral evaluation of Huntington\u2019s disease transgenic and knock-in mouse models","volume":"35","author":"Menalled","year":"2009","journal-title":"Neurobiol Dis"}],"container-title":["NAR Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/narmolmed\/advance-article-pdf\/doi\/10.1093\/narmme\/ugag023\/68195536\/ugag023.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/narmolmed\/article-pdf\/3\/2\/ugag023\/68195536\/ugag023.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/narmolmed\/article-pdf\/3\/2\/ugag023\/68195536\/ugag023.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:57:03Z","timestamp":1778569023000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/narmolmed\/article\/doi\/10.1093\/narmme\/ugag023\/8665776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3,30]]}},"URL":"https:\/\/doi.org\/10.1093\/narmme\/ugag023","relation":{},"ISSN":["2976-856X"],"issn-type":[{"value":"2976-856X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,3,30]]},"article-number":"ugag023"}}